Seaweed extract shows promise in treating H. pylori-related diseases, gastric cancer
A unique seaweed extract shows promise for the treatment of Helicobacter pylori-related diseases and gastric cancer, according to new research undertaken at the University of Western Australia.
Helicobacter pylori (H. pylori) is a bacteria that infects more than half of the human population worldwide. Infection of this bacteria is a primary cause of chronic stomach inflammation, peptic ulcer diseases and gastric cancers, leading to more than one million deaths per year.
Effective treatments for H. pylori are limited with a rising percentage of treatment failures, primarily due to antibiotic resistance. Alternative and additional treatment options are widely recognised as a significant global healthcare issue. Results from this latest study show that fucoidan, a sulphated polysaccharide found in brown seaweed, may offer a solution.